Form4insider filings, from the source

SEC Form 4 · accession 0001578259-15-000045

NOVELION THERAPEUTICS INC. · NVLN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jason Aryeh
Director
Period of report
Jun 7, 2015
Accepted (ET)
Jun 9, 2015 · 8:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common SharesF1Jun 7, 2015M8,000—A167,078D
Common SharesF1Jun 7, 2015M12,000—A179,078D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1,F2,F4—Jun 7, 2015M8,000D——Common Shares8,0000D
Restricted Stock UnitF1,F3,F4—Jun 7, 2015M12,000D——Common Shares12,0000D

Explanation of responses